Background: Regulatory T cells (Tregs) and B cells (Bregs) play an important role in the development of lung cancer. The present study aimed to investigate the phenotype of circulating Tregs and Bregs in patients with lung cancer and explore potential mechanism by which lung cancer cells act on the development of both.
Introduction
Lung cancer is the most prevalent malignant tumor and the leading cause of cancer-associated morbidity and mortality [1] . Over 1.4 million people were diagnosed with lung cancer in 2004 and about 1.3 million people die of lung cancer each year, according to the Global Burden of Disease study [2] . Both tumor characteristics immune responses of patients with lung cancer could affect tumor development [3] . Growing evidence has proposed an opposing role of the immune system in fostering tumor growth, in spite of the considerable evidence indicating that the immune system can recognize and destroy tumor cells [4] [5] [6] .
Regulatory T cells (Tregs) are a subpopulation of T cells with immune suppressive function. Recent studies demonstrated elevated percentages of Tregs in the total T cell population isolated from tumor tissues or peripheral blood in a variety of cancers, including lung cancer [7] [8] [9] . The accumulation of Tregs might be associated with advanced tumor growth and poor prognosis in lung cancer [10] [11] [12] . Regulatory B cells (Bregs) were also found to play a regulatory role in immune responses via the production of regulatory cytokines, such as IL-10 and TGF-β, and express inhibitory molecules to suppress pathogenic T cells and autoreactive B cells in a cell-to-cell contact-dependent manner [13, 14] . The absence or loss of Bregs may exacerbate disease symptoms in autoimmune diseases [15] , chronic inflammatory diseases [16] , or promot tumor progression. It was reported that Bregs played a critical role in pulmonary metastasis of breast cancer through inducing recruitment and expansion of Tregs [17] . In developing tumors anti-tumorigenic and pro-tumorigenic immune and inflammatory mechanisms coexist, and the net effect of them affects tumor development [18] . However, there are few studies on the role of Bregs in lung cancer and the potential interaction of lung cancer cells on the development of Treg and Breg. The present study aimed to investigate the phenotype of circulating Tregs and Bregs in patients with lung cancer and explore potential mechanism by which lung cancer cells act on the antitumor immunity.
Patients and methods

Blood samples collection
Peripheral blood samples were collected upon patient admission before any therapeutic intervention. The diagnosis of lung cancer was made on the basis of imaging or biopsy examination (n = 268). Control samples were obtained from healthy donors (n = 65). All blood samples were collected after informed consent was given. The present study was approved by the Ethical Evaluation Committee of Zhongshan Hospital.
Cell isolation and culture
Peripheral blood mononuclear cells (PBMC) were isolated as previously described [19] . In brief, whole blood samples were overlaid onto Ficoll separation media (Tianjin Haoyang Biological Manufacture, China) after 1:1 dilution with Hank's Balanced Salted Solution (Gibco, CA, USA). PBMCs were centrifuged for 15 min at × 2800 rpm, collected at the plasma interface and washed thrice after centrifugation at × 1500 rpm for 10 min. Human alveolar adenocarcinoma cell line A549, which were from our research center, and the isolated PBMCs were cultured in DMEM (high glucose, Hyclone, USA), supplemented with 10% FBS (Hyclone, USA), 100U/ml penicillin, and 100 μg/ ml streptomycin at 37°C in a 5% CO 2 , 95% air environment in humidified incubators.
Transwell experiment
Twelve-well transwell chambers with a 0.4 μm porous membrane (Corning-Costar, USA) were used. A549 cells (5 × 10 5 /well) were plated underneath the transwell chamber and stimulated with LPS, and then 0.5 ml of PBMC (2 × 10 6 /ml) was added to the inner chamber at 24 hrs after LPS stimulation. After co-culturing for 48 hrs, PBMCs were harvested and stained by flow cytometry, while A549 cells were harvested and prepared for quantitative real time polymerase chain reaction (qRT-PCR). To investigate the role of LPS-related signal pathway, A549 cells were pretreated with NF-κB inhibitor PDTC at 10, 50, 100, 300, or 500 μM for 4 hrs.
Flow cytometry analysis
Flow cytometry analysis was conducted by FACS Aria II flow cytometry (BD Bioscience, USA). For surface staining, suspensions of PBMCs were stained on ice using predetermined optimal concentrations of each antibody for 30 min, and fixed using fixation buffer (BD PharMingen, USA). Tregs identified with CD4
− expression were stained with human regulatory T cell Cocktail (BD PharMingen, USA) [20] and Bregs identified with CD19 + CD24 hi CD27 + expression were stained with human anti-CD19, human anti-CD24, and human anti-CD27 (BD PharMingen, USA) [21] . Intracellular IL-10 analysis was performed by flow cytometry, as described previously [22] . Briefly, cells were resuspended (2 × 10 6 cells/ml) in medium and stimulated with ODN2006 (10 μg/ml; Sangon Biotech, Shanghai, China) for 24 hrs with leukocyte activation cocktail (2 μl/ml; BD GolgiPlug™, BD Pharmingen, USA) added during the final 5 hrs before staining. After surface staining, cells were fixed, permeabilized using a Cytofix/Cytoperm™ Kit (BD PharMingen, USA), and stained with human anti-IL10 (BD PharMingen, USA) according to the manufacturer's instructions. Results are expressed as frequency of Tregs or Bregs.
Quantitative real time polymerase chain reaction (qRT-PCR)
RNA extraction was performed using the TRIZOL™LS reagent (Invitrogen, Carlsbad, CA). cDNA was prepared using PrimeScript® RT reagent Kit (Takara, Shiga, Japan) following standard protocols. qRT-PCR was performed using SYBR® Premix Ex Taq™ (Takara, Shiga, Japan) on the ABI PRISM 7900 real-time PCR system (Applied Biosystems, Foster City, CA). All samples were run in triplicate. Results are shown as relative target mRNA levels. Figure S1B ). 4. To investigate the role of LPS-related NF-κB signal pathway in the activation of lung cancer cells. A549 cells were planted in the lower chamber of the transwell and pretreated with NF-κB inhibitor PDTC at 10, 50, 100, 300, 500 μM or vehicle for 4 hrs, and then washed with fresh medium. After then, PDTC pre-treated A549 cells were stimulated with LPS at 500 ng/ml for 24 hrs and PBMCs from healthy donors were added to the upper chamber of the transwell for co-culture for 48 hrs. Treg frequencies were enumerated by flow cytometry (Additional file 1: Figure S1C ). 5. To investigate the role of inflammation-activated lung cancer cells in phenotype alterations of PBMC obtained from patients with lung cancer and the phenotype difference between lung cancer patients and healthy individuals. A549 cells were stimulated with LPS at 100 and 500 ng/ml for 24 hrs, and LPS-stimulated A549 cells and their supernatant were then harvested. PBMC from lung cancer patients were co-cultured with harvested LPSstimulated A549 cells and their supernatant for 48 hrs, respectively. The control group was PBMC from lung cancer patients without co-culture. Treg and Breg frequencies were enumerated by flow cytometry (Additional file 1: Figure S1D ). 
Experimental design
Statistical analysis
All values were expressed as mean ± SEM. Statistical analysis was performed using SPSS software (SPSS 20.0; SPSS Inc; Chicago, IL). Frequencies of peripheral Tregs and Bregs among groups were analyzed with one-way ANOVA, followed by an unpaired student's ttest. P <0.05 was considered as statistically significant.
Results
Frequencis of CD4
+ T cells and CD19 + B cells in PBMCs from patients with lung cancer significantly decreased as compared with healthy individuals (P <0.001, Figure 1A Figure 4C showed significantly increased frequencies of Tregs in a concentration-dependent pattern, while a decreased frequency of CD45RA + Tregs at 100 ng/ml of LPS. The frequency significantly increased to the highest level at 500 ng/ml of LPS (P <0.05; Figure 4D Figure 4E and F, respectively) .
To investigate the role of LPS-related signal pathway in the interaction between cancer cells and immune cells, A549 cells were pretreated with or without the NF-κB inhibitor PDTC at 10, 50, 100, 300, or 500 μM for 4 hrs, followed by the stimulation of LPS at 500 ng/ ml. Figure 5A demonstrated that PDTC-pretreated A549 cells significantly increased frequencies of CD4 + T cells, while decreased frequencies of Tregs and CD45RA + Tregs when A549 cells were pretreated with PDTC at 300 μM ( Figure 5B and C) . Figure 6A and B showed a significantly increased mRNA expression of RANTES and MIP-1α in A549 in a concentration-dependent pattern after co-culture, which accompanied the upregulation of Tregs ( Figure 4C ). mRNA expression of TGF-β in PBMC significantly reduced ( Figure 6C ), but IFN-γ and IL-4 in PBMC increased after co-culture ( Figure 6D and E). Co-culture of PBMCs from lung cancer patients with A549 cells and conditioned supernatant stimulated with LPS at 100 and 500 ng/ml induced alterations in PBMC populations compared to those observed in PBMCs from healthy donors. Figure 7A demonstrated that coculture with LPS-stimulated A549 cells or conditioned Figure 5 The role of LPS-related NF-κB signal pathway in the activation of lung cancer cells (A549). A549 cells were planted in the lower chamber of the transwell and pretreated with NF-κB inhibitor PDTC at 10, 50, 100, 300, 500 μM or vehicle for 4 hrs, and then washed with fresh medium. PDTC pre-treated A549 cells were stimulated with LPS at 500 ng/ml for 24 hrs and PBMCs from healthy donors were then added to the upper chamber of the transwell for co-culture for 48 hrs. (Figure 7E and F) . It seemed that alterations of Bregs were mainly cytokines dependent.
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Discussion
The immune system plays a significant role in the control of tumor progression, although the regulatory mechanism of interaction between two systems remains unclear. High proportions of Tregs were found in tumor-infiltrating lymphocytes of patients with lung cancer [7] and Tregs from patients with lung cancer directly inhibited autologous T cell proliferation [23] . The percentage of Tregs might be correlated with the pathological stage in lung cancer or tumor burden [24] . The present study demonstrated that peripheral frequencies of Tregs and CD45RA + Tregs in lung cancer patients was lower than those in healthy individuals, indicating a maturationactivation state of naïve Tregs and preferential homing Tumor cells play a crucial role in the conversion of naïve and/or effector T cells into Treg by providing antigenic stimulation and cytokines, although little has been known on the influence of cytokines on Treg proliferation or activation during the interaction between tumor and inflammatory cells. The previous study demonstrated that overexpression of RANTES was associated with improved prognosis in lung cancer [28] . Lung cancer cells were found to produce MIP-1α which might affect the interaction between lung cancer and host inflammatory cells [29] . The present study observed that mRNA expressions of RANTES and MIP-1α in cancer cells after co-culture of cancer cells and PBMCs in a concentration-dependent pattern, accompanied with the up-regulation of Tregs.
Interaction between PBMCs and inflammation-activated cancer cells or their products also increased the frequency of CD19 On basis of our finding that co-culture led to phenotype alterations of PBMCs from healthy individuals, we further investigated the role of inflammation-activated cancer cells in PBMCs from patients with lung cancer and found similar alterations of Treg and CD45RA + Treg phenotypes in PBMC from lung cancer patients to those in healthy donors. However, the interaction between PBMCs from lung cancer patients with inflammationactivated cancer cells decreased the frequency of Bregs, which might be explained by the immune state of cancer patients. Growing evidence has shown interaction between Tregs and Bregs in tumor microenvironment. A previous study revealed that Bregs in the lung metastasis from breast cancer were able to induce conversion of resting CD4 + T cells to Tregs to support metastatic growth [17] . The observation might also explain the expansion of Tregs in our co-culture-model. More investigations are needed to further explore the interactions between Tregs and Bregs and the underlying mechanism, involving mediators from both Tregs and Bregs or potential network biomarkers [30] [31] [32] [33] [34] [35] [36] [37] [38] .
In conclusion, we found decreased or increased frequencies of peripheral Tregs or Bregs in patients with lung cancer where the direct interaction of inflammationactivated cancer cells may play the critical and dominant roles (Additional file 2: Figure S2 ). Effects of lung cancer cells were associated with the severity of inflammation. Further studies are needed to reveal the underlying mechanisms leading to the alterations of lymphocyte phenotypes. Strategies against regulatory lymphocytes may be potential for tumor therapy in the future.
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